BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25815853)

  • 1. Imaging tumor metabolism using in vivo magnetic resonance spectroscopy.
    Li Y; Park I; Nelson SJ
    Cancer J; 2015; 21(2):123-8. PubMed ID: 25815853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor imaging using hyperpolarized 13C magnetic resonance spectroscopy.
    Brindle KM; Bohndiek SE; Gallagher FA; Kettunen MI
    Magn Reson Med; 2011 Aug; 66(2):505-19. PubMed ID: 21661043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance spectroscopy in clinical oncology.
    Golder W
    Onkologie; 2004 Jun; 27(3):304-9. PubMed ID: 15249722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of multinuclear in vivo magnetic resonance spectroscopy in oncology].
    Semmler W; Gückel F; Bachert-Baumann P; Lorenz WJ; van Kaick G
    Radiologe; 1989 Jul; 29(7):330-5. PubMed ID: 2667032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?
    Vion-Dury J; Meyerhoff DJ; Cozzone PJ; Weiner MW
    J Neurol; 1994 May; 241(6):354-71. PubMed ID: 7931430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of Metabolism Using (13)C MRS of Hyperpolarized Probes.
    Chaumeil MM; Najac C; Ronen SM
    Methods Enzymol; 2015; 561():1-71. PubMed ID: 26358901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile synthesis [5-(13)C-4-(2)H(2)]-L-glutamine for hyperpolarized MRS imaging of cancer cell metabolism.
    Qu W; Zha Z; Lieberman BP; Mancuso A; Stetz M; Rizzi R; Ploessl K; Wise D; Thompson C; Kung HF
    Acad Radiol; 2011 Aug; 18(8):932-9. PubMed ID: 21658976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
    Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
    J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of hyperpolarized (13)C MRI in assessing signaling pathways in cancer.
    Zhang H
    Acad Radiol; 2014 Feb; 21(2):215-22. PubMed ID: 24439335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR methodologies for studying mitochondrial bioenergetics.
    Alves TC; Jarak I; Carvalho RA
    Methods Mol Biol; 2012; 810():281-309. PubMed ID: 22057574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Musculoskeletal spectroscopy.
    Boesch C
    J Magn Reson Imaging; 2007 Feb; 25(2):321-38. PubMed ID: 17260389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo magnetic resonance spectroscopy of liver tumors and metastases.
    ter Voert EG; Heijmen L; van Laarhoven HW; Heerschap A
    World J Gastroenterol; 2011 Dec; 17(47):5133-49. PubMed ID: 22215937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.
    Zaccagna F; Grist JT; Deen SS; Woitek R; Lechermann LM; McLean MA; Basu B; Gallagher FA
    Br J Radiol; 2018 May; 91(1085):20170688. PubMed ID: 29293376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental strategies for in vivo
    Valette J; Tiret B; Boumezbeur F
    Anal Biochem; 2017 Jul; 529():216-228. PubMed ID: 27515993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promising application of dynamic nuclear polarization for in vivo (13)C MR imaging.
    Yen YF; Nagasawa K; Nakada T
    Magn Reson Med Sci; 2011; 10(4):211-7. PubMed ID: 22214905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of in vivo magnetic resonance spectroscopy for studying metabolic diseases.
    Hwang JH; Choi CS
    Exp Mol Med; 2015 Feb; 47(2):e139. PubMed ID: 25656949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring fluoropyrimidine metabolism in solid tumors with in vivo (19)F magnetic resonance spectroscopy.
    van Laarhoven HW; Punt CJ; Kamm YJ; Heerschap A
    Crit Rev Oncol Hematol; 2005 Dec; 56(3):321-43. PubMed ID: 15982898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment.
    He Q; Xu RZ; Shkarin P; Pizzorno G; Lee-French CH; Rothman DL; Shungu DC; Shim H
    Dis Markers; 2003-2004; 19(2-3):69-94. PubMed ID: 15096706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
    Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
    NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance spectroscopy of cancer metabolism and response to therapy.
    McIntyre DJ; Madhu B; Lee SH; Griffiths JR
    Radiat Res; 2012 Apr; 177(4):398-435. PubMed ID: 22401303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.